ROBERTS ROY S 4
4 · ABBOTT LABORATORIES · Filed Feb 1, 2011
Insider Transaction Report
Form 4
ROBERTS ROY S
Director
Transactions
- Sale
Common shares without par value
2011-01-31$45.15/sh−100$4,515→ 24,128 total - Sale
Common shares without par value
2011-01-31$45.15/sh−100$4,515→ 24,228 total - Exercise/Conversion
Option (right to buy)
2011-01-31−5,616→ 0 totalExercise: $42.73From: 2001-04-27Exp: 2011-04-26→ Common shares (5,616 underlying) - Exercise/Conversion
Common shares without par value
2011-01-31$42.73/sh+5,616$239,987→ 29,344 total - Sale
Common shares without par value
2011-01-31$45.15/sh−2,000$90,302→ 24,728 total - Sale
Common shares without par value
2011-01-31$45.15/sh−8,441$381,111→ 26,728 total - Sale
Common shares without par value
2011-01-31$45.15/sh−400$18,061→ 23,728 total - Exercise/Conversion
Common shares without par value
2011-01-31$41.20/sh+5,825$239,990→ 35,169 total - Sale
Common shares without par value
2011-01-31$45.15/sh−400$18,061→ 24,328 total - Exercise/Conversion
Option (right to buy)
2011-01-31−5,825→ 0 totalExercise: $41.20From: 2004-04-23Exp: 2014-04-22→ Common shares (5,825 underlying)
Footnotes (1)
- [F1]Stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exepmt from Section 16 under Rule 16b-3.